[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Shin et al., 1999 - Google Patents

Synthesis and hypoglycemic effect of chrysin derivatives

Shin et al., 1999

Document ID
7819614303940196421
Author
Shin J
Kim K
Kim M
Jeong J
Kim B
Publication year
Publication venue
Bioorganic & Medicinal Chemistry Letters

External Links

Snippet

A series of 18 chrysin derivatives, prepared by alkylation and condensation, were fully characterized by NMR and other techniques and tested in vivo against the diabetes mellitus. Several modified compounds especially those with propyl, butyl, octyl and tolyl groups were …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, -CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Similar Documents

Publication Publication Date Title
Shin et al. Synthesis and hypoglycemic effect of chrysin derivatives
JP4397688B2 (en) Use of stilbene compounds in the manufacture of a medicament for the prevention and treatment of diabetes or retrovirus-related diseases
TWI284641B (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
KR101192272B1 (en) Compounds for the treatment of metabolic disorders
CN1950376B (en) Curcumol derivatives, compositions comprising the same and use in manufacture of medicament
CA2545479A1 (en) Compounds comprising a nitric oxide moiety for inducing expression of apoa1 for the treatment of cardiovascular disorders
US7109232B2 (en) Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity
CN113730391A (en) Application of myrtle ketone compound in preparation of medicine for resisting novel coronavirus SARS-CoV-2
TW200840561A (en) Composition for treating cancer cells and synthesis method thereof
Uenlue et al. Synthesis and Analgesic and Anti‐inflammatory Activity of Some New (6‐Acyl‐2‐benzoxazolinone and 6‐Acyl‐2‐benzothiazolinone Derivatives with Acetic Acid and Propanoic Acid Residues
WO2003105751A2 (en) Novel curcumin derivatives
CN108840871B (en) 13-hydroxy cytisine cinnamate compound with anti-tumor activity and preparation method thereof
CN109970558B (en) Cebatrien-4-ol-6-carboxylate and its preparation method and application
CN113735814A (en) Myrtle ketone compound and application thereof in preparation of anti-influenza virus drugs
JP2005247724A5 (en)
JP2005247724A (en) New mixture and compound obtained from mycelium of antrodia camphorata, and use thereof
CN107082754A (en) A kind of cinnamic acid derivative with aldose reductase inhibition activity and its production and use
CN111393421B (en) Butenolide derivative and preparation method and application thereof
WO2002083625A1 (en) Ferulic acid dimers and their pharmaceutically acceptable salts, their preparation and use thereof for treating dementia
KR100604696B1 (en) Novel curcumin derivatives
JPS63264580A (en) 3-(2-haloalkyl)-1,4-oxathiin and 2-(2- haloalkyl)-1,4-dithiin
CN115583890B (en) Medicament for treating dyslipidemia and application thereof
EP0096008B1 (en) (+)-cyanidan-3-ol derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter
TW201018462A (en) Novel mixture and compounds from mycelia of antrodia camphorata having hepatoprotection, anti-inflammatory and anti-tumor activities
CN109053701A (en) Arctiin metaclass compound, preparation method and purposes